Strainprint Technologies Ltd. Platinum Sponsor @ O'Cannabiz
On June 7-9th Strainprint participated in O’Cannabiz as a platinum sponsor. The weekend was filled with insightful panels, productive industry discussions, and invaluable networking! Have a look at our round-up from the action-packed weekend below! We look foward to next year!
Strainprint Technologies Ltd. & Emblem Cannabis on Humble & Fred Radio
On Wednesday, July 11th, 2018 Strainprint President & CTO, David Berg, and COO of Emblem Cannabis Corp, Adam Saperia had the opportunity to appear on the Humble & Fred Radio show where they talked about the benefits of medical cannabis, patient tracking and how data is helping to shape the future of the cannabis industry.
Strainprint Participates in CannabisFest
On July 10th, 2018 Strainprint had the opportunity to participate in CannabisFest where our Founder, Stephanie Karasick participated in an AMA focused on how Entrepreneurs can prepare for legalization. https://betakit.com/cannabisfest-explores-how-entrepreneurs-can-prepare-for-legalization/
Strainprint Technologies Ltd. Featured in The Growth Op
Recently, Strainprint Founder Stephanie Karasick was featured in The Growth Op. Here she talks about the launch of the Strainprint app that helped, and continues to help her and tens of thousands of other patients keep track of their medical marijuana dosage. Read more about Steph’s journey, and Strainprint here: https://www.thegrowthop.com/cannabis-business/cannabis-experts/when-it-comes-to-cannabis-prescriptions-sometimes-less-is-more
Strainprint Technologies Ltd. – Steph’s Story
We are proud to present the genesis of Strainprint. Steph’s story is what defines us. With her story, and 1,000’s more like it we will continue to break the stigma & pave the way for the future of the cannabis industry. Have a look at Steph’s story, and if it resonates with you, consider sharing! […]
Strainprint™ Closes USD $3 Million (Cdn.$3.8M) Series A Funding
TORONTO, May 8, 2018 /PRNewswire/ – StrainprintTM Technologies — the leader in cannabis data and analytics is pleased to announce the closing of a USD $3 Million (Cdn.$3.8 Million) non-brokered, Series A private placement. The round was led by strategic industry investor, Cesare Fazari, Chairman of Molecular Science Corp and seed investor of leading cannabis companies, Ample Organics and Hydropothecary. Mr. Fazari […]
WSU uses Strainprint Technologies Data in study
PULLMAN, WA – In a first-of-a-kind study, Washington State University scientists examined how peoples’ self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home. Their work, published this month in the Journal of Affective Disorders, suggests smoking cannabis can significantly reduce short-term levels of depression, anxiety, […]
Strainprint™ Technologies Ltd. ("Strainprint") Welcomes Three Leading Cannabinoid Physicians to its Board
Dr. Caroline MacCallum, Dr. Danial Schecter & Dr. Dean Elterman Join Strainprint’s World-Class Medical Advisory Board TORONTO, April 17, 2018 /CNW/ – Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely […]
Strainprint President & CTO, David Berg Featured in Cannabis Investing News
The legalization of cannabis has allowed researchers to begin investigating the drug at more in-depth levels than before. With the current state of cannabis working towards legalization across the globe, new channels of research are opening up across the board as an effort to rapidly catch up with a market ready to consume a product […]